Ocrelizumab Extended Interval Dosing in Primary Progressive Multiple Sclerosis: An Italian Experience.

Autor: Zanghì A; Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy., Ferraro D; University of Modena and Reggio Emilia, Moderna, Emilia-Ronagna, Italy., Callari G; IRCSS G.Giglio, Cefalù, Italy., Valentino P; Azienda Ospedaliera Universitaria 'Mater Domini', Catanzaro, Italy., Granella F; Unit of Neurosciences, Department of Medicine and Surgery, University of Parma, Parma, Italy.; Multiple Sclerosis Centre, Department of General Medicine, Parma University Hospital, Parma, Italy., Patti F; Department 'G.F. Ingrassia', MS Center University of Catania, Catania, Italy., Lus G; Multiple Sclerosis Center, II Division of Neurology, Department of Clinical and Experimental Medicine, Second University of Naples, Naples, Italy., Bonavita S; Dipartimento di Scienze Mediche e Chirurgiche Avanzate, Università della Campania Luigi Vanvitelli, Piazza Miraglia, 2, 80138 Naples, Italy., Moretti MC; Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy., Avolio C; Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy., D'Amico E; Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.

Publikováno v: Current neuropharmacology [Curr Neuropharmacol] 2024; Vol. 22 (2), pp. 339-345.

Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies

Autor: Sormani M. P., Schiavetti I., Carmisciano L., Inglese M., Laroni A., Lapucci C., Uccelli A., Da Rin G., Serrati C., Gandoglia I., Tassinari T., Perego G., Brichetto G., Gazzola P., Mannironi A., Stromillo M. L., Cordioli C., Landi D., Clerico M., Signoriello E., Frau J., Ferro M. T., Di Sapio A., Pasquali L., Ulivelli M., Marinelli F., Callari G., Iodice R., Liberatore G., Caleri F., Repice A. M., Cordera S., Battaglia M. A., Salvetti M., Franciotta D., Maglione A., Signori A., Iovino A., Nicoletti C. G., Mancinelli C. R., Bezzini D., Carmagnini D., Brogi D., Orazio E. N., Cocco E., Nako E., Assandri E., Baldi F., Ansaldi F., Bovis F., Siciliano G., Cola G., Lus G., Icardi G., bellucci G., Rin G. D., Marfia G. A., Vazzoler G., Trivelli G., Maietta I., Sticchi L., Lorefice L., Ruggiero L., Manzino M., Bragadin M. M., Buscarinu M. C., Gagliardi M., Rilla M. T., Ponzano M., Fronza M., Sette M. D., Scialabba M., Bedognetti M., De Rossi N., De Stefano N., Bigi R., Dubbioso R., Renie R., Fabbri S., Rasia S., Rolla S., Platzgummer S., Carlini V.

Publikováno v: EBioMedicine, Vol 72, Iss, Pp 103581-(2021)
EBioMedicine

Background: In patients with Multiple Sclerosis (pwMS) disease-modifying therapies (DMTs) affects immune response to antigens. Therefore, post-vaccination serological assessments are needed to evaluate the effect of the vaccine on SARS-CoV-2 antibody

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::261101604158c2741aadffad00fb60a7
http://hdl.handle.net/11567/1060214

Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study.

Autor: Baroncini D; Multiple Sclerosis Center, Gallarate Hospital, ASST Valle Olona, Gallarate, VA, Italy. damianobaroncini@gmail.com., Ghezzi A; Multiple Sclerosis Center, Gallarate Hospital, ASST Valle Olona, Gallarate, VA, Italy.; Dipartimento Di Scienze Della Salute, Università del Piemonte Orientale, Novara, Italy., Guaschino C; Multiple Sclerosis Center, Gallarate Hospital, ASST Valle Olona, Gallarate, VA, Italy., Moiola L; Multiple Sclerosis Center-Neurology Department, San Raffaele Hospital IRCCS, Milano, Italy., Filippi M; Department of Neurology, Neurorehabilitation and Neurophysiology, MS Center, and Neuroimaging Research Unit, Vita-Salute San Raffaele University and San Raffaele Scientific Institute, Milan, Italy., Ianniello A; Department of Human Neurosciences, S.Andrea Multiple Sclerosis Center, Sapienza University, Rome, Italy., Pozzilli C; Department of Human Neurosciences, S.Andrea Multiple Sclerosis Center, Sapienza University, Rome, Italy., Lanzillo R; Department of Neurosciences and Reproductive and Odontostomatological Sciences, University 'Federico II', Naples, Italy., Brescia-Morra V; Department of Neurosciences and Reproductive and Odontostomatological Sciences, University 'Federico II', Naples, Italy., Margoni M; Multiple Sclerosis Centre of the Veneto Region (CeSMuV), University Hospital of Padua, Padua, Italy.; Padova Neuroscience Centre (PNC), University of Padua, Padua, Italy., Gallo P; Multiple Sclerosis Centre of the Veneto Region (CeSMuV), University Hospital of Padua, Padua, Italy.; Padova Neuroscience Centre (PNC), University of Padua, Padua, Italy., Callari G; Foundation Institute 'G. Giglio', MS Center, Cefalù-Palermo, Italy., Grimaldi L; Foundation Institute 'G. Giglio', MS Center, Cefalù-Palermo, Italy., Lus G; Multiple Sclerosis Center, II Division of Neurology, Department of Clinical and Experimental Medicine, University of Campania 'L. Vanvitelli', Naples, Italy., Calabrese M; Department of Neuroscience, Biomedicine and Movement, The Multiple Sclerosis Center of the University Hospital of Verona, Verona, Italy., Simone M; Child Neuropsychiatry Unit, Department of Biomedical Sciences and Human Oncology, University of Bari 'Aldo Moro', Bari, Italy., Marfia GA; MS Clinical and Research Unit, Department of Systems Medicine, Tor Vergata University, Rome, Italy., Rasia S; Multiple Sclerosis Center, ASST - Spedali Civili of Brescia, Montichiari, Brescia, Italy., Cargnelutti D; Neurology Unit, Udine University Hospital, Piazzale Santa Maria della Misericordia 15, 33100, Udine, Italy., Comi G; Multiple Sclerosis Center, Gallarate Hospital, ASST Valle Olona, Gallarate, VA, Italy.; Casa Di Cura del Policlinico, Milan, Italy., Zaffaroni M; Multiple Sclerosis Center, Gallarate Hospital, ASST Valle Olona, Gallarate, VA, Italy.

Publikováno v: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2022 Nov; Vol. 43 (11), pp. 6415-6423. Date of Electronic Publication: 2022 Jul 04.

Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy.

Autor: Sormani MP; Department of Health Sciences, Section of Biostatistics, University of Genova, Italy; IRCCS Ospedale Policlinico San Martino, Genova, Italy. Electronic address: mariapia.sormani@unige.it., Schiavetti I; Department of Health Sciences, Section of Biostatistics, University of Genova, Italy., Inglese M; IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI) and Center of Excellence for Biomedical Research (CEBR), University of Genoa, Genoa, Italy., Carmisciano L; Department of Health Sciences, Section of Biostatistics, University of Genova, Italy., Laroni A; IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI) and Center of Excellence for Biomedical Research (CEBR), University of Genoa, Genoa, Italy., Lapucci C; IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI) and Center of Excellence for Biomedical Research (CEBR), University of Genoa, Genoa, Italy., Visconti V; Laboratory Medicine, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Serrati C; Department of Neurology, Imperia Hospital, Imperia, Italy., Gandoglia I; Neurology Unit, Galliera Hospital, Italy., Tassinari T; S.C. Neurologia - Ospedale Santa Corona Pietra Ligure (Sv), Italy., Perego G; SC Neurologia ASL 4 Chiavarese, Italy., Brichetto G; AISM Rehabilitation Center, Genoa, Italy., Gazzola P; Centro Sclerosi Multipla S.C. Neurologia Asl 3 Genovese, Italy., Mannironi A; Department of Neurology, Sant'Andrea Hospital, La Spezia, Italy., Stromillo ML; Clinica Neurologica e Malattie Neurometaboliche, Università degli Studi di Siena, Italy., Cordioli C; Centro Sclerosi Multipla ASST Spedali Civili di Brescia, Italy., Landi D; Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, Tor Vergata University and Hospital, Rome, Italy., Clerico M; Dipartimento di Scienze Cliniche e Biologiche, Università di Torino, Italy., Signoriello E; Centro Sclerosi Multipla, II Clinica Neurologica, Università della Campania Luigi Vanvitelli, Italy., Cocco E; Centro Sclerosi Multipla Ospedale Binaghi Cagliari - ATS Sardegna, Università di Cagliari, Italy., Frau J; Centro Sclerosi Multipla Ospedale Binaghi Cagliari - ATS Sardegna, Università di Cagliari, Italy., Ferrò MT; Neuroimmunology, Center for Multiple Sclerosis, Cerobrovascular Department, Neurological Unit, ASST Crema, Italy., Di Sapio A; Department of Neurology, Regina Montis Regalis Hospital, Mondovì, Italy., Pasquali L; Department of Clinical and Experimental Medicine, Neurology Unit, University of Pisa, Italy., Ulivelli M; Department of Medicine, Surgery and Neuroscience, University of Siena, Italy., Marinelli F; Multiple Sclerosis Center, Fabrizio Spaziani Hospital, Frosinone, Italy., Pizzorno M; Neurologia, Ospedale San Paolo, Savona, Italy., Callari G; UOC Neurologia e Centro SM Fondazione Istituto G. Giglio, Cefalù, Italy., Iodice R; Clinica Neurologica, DSNRO Università Federico II di Napoli, Italy., Liberatore G; Neuromuscular and Neuroimmunology Service, IRCCS Humanitas Research Hospital, Rozzano, Italy., Caleri F; MS Center, Department of Neurology, F. Tappeiner Hospital Meran (BZ), Italy., Repice AM; Department of Neurology 2, Careggi University Hospital, Florence, Italy., Cordera S; Department of Neurology, Ospedale Regionale, Aosta, Italy., Battaglia MA; Research Department, Italian Multiple Sclerosis Foundation, Genoa, Italy; Department of Life Sciences, University of Siena, Italy., Salvetti M; Centre for Experimental Neurological Therapies (CENTERS), Department of Neurosciences, Mental Health and Sensory Organs, Sapienza University of Rome, Italy; IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli, Italy., Franciotta D; Autoimmunology Laboratory, IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Uccelli A; IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI) and Center of Excellence for Biomedical Research (CEBR), University of Genoa, Genoa, Italy.

Publikováno v: EBioMedicine [EBioMedicine] 2022 Jun; Vol. 80, pp. 104042. Date of Electronic Publication: 2022 May 05.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.